Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
Mark Raza Principal Deputy Chief Counsel - FDA | Official Website
This is a 57.1% increase over the number of companies inspected in the previous quarter, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected worked in the Drugs sector.
There were six companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions (54.5%). Five should take voluntary action to correct their management operations (45.5%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Gulf Rice Milling, Inc. | Food and Cosmetics | 06/11/2024 | No Action Indicated (NAI) |
Hans Lee, M.D. | Drugs | 04/19/2024 | No Action Indicated (NAI) |
Kong Ju Food, Inc. | Food and Cosmetics | 06/12/2024 | Voluntary Action Indicated (VAI) |
Quality Bakery Products, Inc. | Food and Cosmetics | 04/22/2024 | Voluntary Action Indicated (VAI) |
Ruiz Distributing Company | Food and Cosmetics | 05/10/2024 | No Action Indicated (NAI) |
Schoenmann Produce Company | Food and Cosmetics | 04/03/2024 | Voluntary Action Indicated (VAI) |
Tex-Mex Produce, LLC | Food and Cosmetics | 05/15/2024 | No Action Indicated (NAI) |
Topway Enterprises, Inc. | Food and Cosmetics | 05/08/2024 | No Action Indicated (NAI) |
Univar Solutions USA, Inc. | Food and Cosmetics | 05/01/2024 | Voluntary Action Indicated (VAI) |
University of Texas Health Science Center at Houston IRB | Biologics | 04/19/2024 | No Action Indicated (NAI) |
University of Texas Health Science Center at Houston IRB | Devices | 04/19/2024 | No Action Indicated (NAI) |
University of Texas Health Science Center at Houston IRB | Drugs | 04/19/2024 | No Action Indicated (NAI) |
Us Gulf Coast Trading Company, Inc. | Food and Cosmetics | 06/04/2024 | Voluntary Action Indicated (VAI) |